Primary Tumor Versus Liver-First Approach for Synchronous Colorectal Liver Metastases: An Association Française de Chirurgie (AFC) Multicenter-Based Study with Propensity Score Analysis

2018 ◽  
Vol 42 (12) ◽  
pp. 4046-4053 ◽  
Author(s):  
Francesco Esposito ◽  
◽  
Chetana Lim ◽  
Antonio Sa Cunha ◽  
Patrick Pessaux ◽  
...  
2017 ◽  
Vol 402 (1) ◽  
pp. 57-67 ◽  
Author(s):  
Damien Bergeat ◽  
Michel Rayar ◽  
Yann Mouchel ◽  
Aude Merdrignac ◽  
Bernard Meunier ◽  
...  

2017 ◽  
Vol 116 (2) ◽  
pp. 149-158 ◽  
Author(s):  
Moritz J. Strowitzki ◽  
Thomas Schmidt ◽  
Ulrich Keppler ◽  
Alina S. Ritter ◽  
Sarah Mahmoud ◽  
...  

BJS Open ◽  
2019 ◽  
Vol 3 (4) ◽  
pp. 521-531 ◽  
Author(s):  
K. M. Brown ◽  
M. F. Albania ◽  
J. S. Samra ◽  
P. J. Kelly ◽  
T. J. Hugh

2020 ◽  
Author(s):  
Yuanping Zhang ◽  
Yongjin Wang ◽  
Yichuan Yuan ◽  
Jiliang Qiu ◽  
Yuxiong Qiu ◽  
...  

Abstract Background: Whether primary tumor location of colorectal cancer (CRC) affects survival of patients after resection of liver metastases remains controversial. This study was conducted to investigate the differences in clinicopathological characteristics and prognosis between right-sided CRC and left-sided CRC patients with liver metastases after hepatectomy. Methods: From 2002 to 2018, 611 patients with colorectal liver metastases (CRLM) who underwent hepatectomy at our center were reviewed. Primary tumors located from cecum to transverse colon were defined as right-sided group (n = 141); tumors located from splenic flexure to rectum were defined as left-sided group (n = 470). Patients were compared between two groups before and after a 1:1 propensity score matching (PSM) analysis. Results: Before PSM, median survival time and 5-year overall survival (OS) rate in right-sided group were 77 months and 56.3%, and those in left-sided group were 64 months and 51.1%, respectively. After PSM, median survival time and 5-year OS rate in right-sided group were 77 months and 55.9%, and those in left-sided group were 58.8 months and 47.3%, respectively. The OS rates did not differ between two groups before and after PSM (P = 0.575; P = 0.453). However, significant different recurrence-free survival (RFS) rate was found before and after PSM between right-sided and left-sided group (P = 0.028, P = 0.003). Conclusions: Compared to patients with left-sided primary tumors, patients with right-sided primary tumors had a worse RFS but similar OS. Careful preoperative evaluation, intensive preoperative chemotherapy and frequent follow-up to detect early recurrence might be justified for CRLM patients with right-sided primary tumors.


Sign in / Sign up

Export Citation Format

Share Document